83 related articles for article (PubMed ID: 24324075)
1. Associations of cyclooxygenase 2 polymorphic genotypes with bladder cancer risk in Taiwan.
Chang WS; Tsai CW; Ji HX; Wu HC; Chang YT; Lien CS; Liao WL; Shen WC; Tsai CH; Bau DT
Anticancer Res; 2013 Dec; 33(12):5401-5. PubMed ID: 24324075
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the contribution of cyclooxygenase 2 genotypes to breast cancer in Taiwan.
Su CH; Hsiao CL; Chang WS; Liu LC; Wang HC; Tsai CW; Li LY; Tsai CH; Bau DT
Anticancer Res; 2014 Nov; 34(11):6711-6. PubMed ID: 25368279
[TBL] [Abstract][Full Text] [Related]
3. Association of Enhancer of Zeste 2 (EZH2) Genotypes with Bladder Cancer Risk in Taiwan.
Chang WS; Liao CH; Tsai CW; Hu PS; Wu HC; Hsu SW; Hsiao CL; Hsu CH; Hung YW; Bau DT
Anticancer Res; 2016 Sep; 36(9):4509-14. PubMed ID: 27630289
[TBL] [Abstract][Full Text] [Related]
4. Association study of cyclooxygenase 2 single nucleotide polymorphisms and childhood acute lymphoblastic leukemia in Taiwan.
Wang CH; Wu KH; Yang YL; Peng CT; Wang RF; Tsai CW; Tsai RY; Lin DT; Tsai FJ; Bau DT
Anticancer Res; 2010 Sep; 30(9):3649-53. PubMed ID: 20944149
[TBL] [Abstract][Full Text] [Related]
5. Significant association of XPD codon 312 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan.
Chang CH; Wang RF; Tsai RY; Wu HC; Wang CH; Tsai CW; Chang CL; Tsou YA; Liu CS; Bau DT
Anticancer Res; 2009 Oct; 29(10):3903-7. PubMed ID: 19846926
[TBL] [Abstract][Full Text] [Related]
6. Association of Matrix Metalloproteinase-7 Genotypes with the Risk of Bladder Cancer.
Liao CH; Chang WS; Tsai CW; Hu PS; Wu HC; Hsu SW; Chen GL; Yueh TC; Shen TC; Hsia TC; Bau DT
In Vivo; 2018; 32(5):1045-1050. PubMed ID: 30388078
[TBL] [Abstract][Full Text] [Related]
7. Significant association of an XRCC4 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan.
Chang CH; Chang CL; Tsai CW; Wu HC; Chiu CF; Wang RF; Liu CS; Lin CC; Bau DT
Anticancer Res; 2009 May; 29(5):1777-82. PubMed ID: 19443403
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in COX-2 gene influence prostate cancer susceptibility in a northern Indian cohort.
Mandal RK; Mittal RD
Arch Med Res; 2011 Oct; 42(7):620-6. PubMed ID: 22023987
[TBL] [Abstract][Full Text] [Related]
9. Significant association of caveolin-1 (CAV1) genotypes with upper urothelial tract cancer.
Chang WS; Lin SS; Li FJ; Tsai CW; Li LY; Lien CS; Liao WL; Wu HC; Tsai CH; Shih TC; Bau DT
Anticancer Res; 2013 Nov; 33(11):4907-12. PubMed ID: 24222128
[TBL] [Abstract][Full Text] [Related]
10. Interaction of cyclooxygenase 2 genotype and smoking habit in Taiwanese lung cancer patients.
Liu CJ; Hsia TC; Wang RF; Tsai CW; Chu CC; Hang LW; Wang CH; Lee HZ; Tsai RY; Bau DT
Anticancer Res; 2010 Apr; 30(4):1195-9. PubMed ID: 20530427
[TBL] [Abstract][Full Text] [Related]
11. Significant association of ERCC6 single nucleotide polymorphisms with bladder cancer susceptibility in Taiwan.
Chang CH; Chiu CF; Wang HC; Wu HC; Tsai RY; Tsai CW; Wang RF; Wang CH; Tsou YA; Bau DT
Anticancer Res; 2009 Dec; 29(12):5121-4. PubMed ID: 20044625
[TBL] [Abstract][Full Text] [Related]
12. Association of cyclooxygenase 2 polymorphic genotypes with prostate cancer in taiwan.
Wu HC; Chang CH; Ke HL; Chang WS; Cheng HN; Lin HH; Wu CY; Tsai CW; Tsai RY; Lo WC; Bau DT
Anticancer Res; 2011 Jan; 31(1):221-5. PubMed ID: 21273602
[TBL] [Abstract][Full Text] [Related]
13. Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for esophageal squmaous cell carcinoma.
Upadhyay R; Jain M; Kumar S; Ghoshal UC; Mittal B
Mutat Res; 2009 Apr; 663(1-2):52-9. PubMed ID: 19428370
[TBL] [Abstract][Full Text] [Related]
14. Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for urinary bladder cancer in North India.
Gangwar R; Mandhani A; Mittal RD
Surgery; 2011 Jan; 149(1):126-34. PubMed ID: 20627335
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism in the nuclear factor kappa-B binding promoter region of cyclooxygenase-2 is associated with an increased risk of bladder cancer.
Kang S; Kim YB; Kim MH; Yoon KS; Kim JW; Park NH; Song YS; Kang D; Yoo KY; Kang SB; Lee HP
Cancer Lett; 2005 Jan; 217(1):11-6. PubMed ID: 15596291
[TBL] [Abstract][Full Text] [Related]
16. [Association between single nucleotide polymorphisms in the promoter of cyclooxygenase COX-2 gene and hereditary susceptibility to pancreatic cancer].
Xu DK; Zhang XM; Zhao P; Cai JC; Zhao D; Tan W; Guo YL; Lin DX
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1961-5. PubMed ID: 19062735
[TBL] [Abstract][Full Text] [Related]
17. Association of functional gene variants in the regulatory regions of COX-2 gene (PTGS2) with nonmelanoma skin cancer after organ transplantation.
Lira MG; Mazzola S; Tessari G; Malerba G; Ortombina M; Naldi L; Remuzzi G; Boschiero L; Forni A; Rugiu C; Piaserico S; Girolomoni G; Turco A
Br J Dermatol; 2007 Jul; 157(1):49-57. PubMed ID: 17578436
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between genetic polymorphism of NAT2 and susceptibility to urinary bladder cancer].
Hao GY; Zhang WD; Chen YH; Zhang DX; Zhang YH
Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):283-6. PubMed ID: 15312364
[TBL] [Abstract][Full Text] [Related]
19. Polymorphic deletions of the GSTT1 and GSTM1 genes and susceptibility to bladder cancer.
Salinas-Sánchez AS; Sánchez-Sánchez F; Donate-Moreno MJ; Rubio-del-Campo A; Gimenez-Bachs JM; Lorenzo-Romero JG; Serrano-Oviedo L; Escribano J
BJU Int; 2011 Jun; 107(11):1825-32. PubMed ID: 20942828
[TBL] [Abstract][Full Text] [Related]
20. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
